Gender Dysphoria in Children and Adolescents : Parents’ Perspectives

Overview

Gender dysphoria is defined as a persistent incongruence between an experienced gender and the assigned sex at birth Transgender and gender nonconforming persons desire to modify their appearance to be consistent with their self-identified gender identities. In non-binary people, contrary to binary transgender persons, self-identified gender identities do not fit the classical pattern male/female. During the last decennium, an increase in the number of young subjects, especially children and adolescents, referred to gender identity centres has been observed. A new nosological entity "rapid-onset gender dysphoria in adolescents and young adults" has recently been described in the literature, whose etiology has not been well understood. This growing demand of adolescents and young adults observed in the recent years is not well understood.

Full Title of Study: “Gender Dysphoria in Children and Adolescents : Parents’ Perspectives”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: December 2020

Interventions

  • Other: qualitative study
    • qualitative research via guided interview

Clinical Trial Outcome Measures

Primary Measures

  • thematic analysis
    • Time Frame: one year
    • The recorde material will be coded using descriptive codes. Conceptual notes will be written, through processes of condensation, comparison and abstracting the initial notes. Connections between notes will be noted and synthesized, and emergent themes will be developed.

Participating in This Clinical Trial

Inclusion Criteria

  • be a parent of a child <18 years followed in the endocrinology department of the University Hospital of Nancy for gender dysphoria – be in stable couple – both parents agree to participate – capacity to communicate in French – Person who has received complete information on the organization of the research and who agreed to the exploitation of the data Exclusion Criteria:

  • Refusal to participate – Inability to be physically, psychologically or linguistically involved in the study

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Central Hospital, Nancy, France
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Eva Feigerlova, MD,PhD, Principal Investigator, University Hospital of Nancy, France
  • Overall Contact(s)
    • Eva Feigerlova, MD, PhD, 00330383153412, e.feigerlova@chru-nancy.Fr

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.